Skip to content
Politically.com Search all
Menu

2026 · 2nd Quarter (Apr 1 - June 30)

PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

Filed by EMPIRE CONSULTING GROUP.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
2nd Quarter - Report
Posted
Jul 20, 2026
Income
$50,000.00
Expenses
Not reported
Filing UUID
9f532be0-e55a-435c-8b86-c510a5866431
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

HR 9504-The Tax-Exempt Hospital Transparency Act. 340B Program Violations. PBM reform. Issues related to Most Favored Nations. Issues related to health access.

Literal federal measure citations: HR 9504

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.